Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis: A Pilot Study.
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab.
Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis.
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
[Anesthesia and Multiple Sclerosis: What needs to be considered?].
Striving for Balance Between Caring and Restraint: Young Adults' Experiences with Parental Multiple Sclerosis.
Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.
Oxidative damage to myelin proteins accompanies peripheral nerve motor dysfunction in aging C57BL/6 male mice.
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial.
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis.
Pages
« first
‹ previous
…
801
802
803
804
805
806
807
808
809
…
next ›
last »